Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stopping clinical trials by design.

John Whitehead1

  • 1Medical and Pharmaceutical Statistics Research Unit, The University of Reading, PO Box 240 Earley Gate, Reading RG6 6FN, UK. j.r.whitehead@reading.ac.uk

Nature Reviews. Drug Discovery
|November 3, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Elicitation of expert prior opinion to design the BARJDM trial in juvenile dermatomyositis.

Rheumatology (Oxford, England)·2024
Same author

Discussion on "The central role of the identifying assumption in population size estimation" by Serge Aleshin-Guendel, Mauricio Sadinle, and Jon Wakefield.

Biometrics·2024
Same author

Inverted laser sintering of metal powders.

Scientific reports·2023
Same author

Perspectives on valuing water quality improvements using stated preference methods.

Proceedings of the National Academy of Sciences of the United States of America·2023
Same author

Why is it so difficult to study magnetic compass orientation in murine rodents?

Journal of comparative physiology. A, Neuroethology, sensory, neural, and behavioral physiology·2022
Same author

Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19.

Statistics in biopharmaceutical research·2021

Clinical trial protocols require interim analyses and stopping rules to ensure participant safety and drug efficacy. Addressing misunderstandings of these rules is crucial for their successful future use in clinical research.

Area of Science:

  • Clinical Trials
  • Biostatistics
  • Medical Ethics

Background:

  • Clinical trial protocols are essential for study validity.
  • Interim analyses and stopping rules are key components of many protocols.
  • Misunderstandings and controversies surround the use of these rules.

Purpose of the Study:

  • To discuss the reasons behind misunderstandings of interim analysis and stopping rules.
  • To propose strategies for promoting the successful and beneficial use of these rules in clinical trials.

Main Methods:

  • The study involves a discussion and analysis of existing literature and practices regarding clinical trial stopping rules.
  • It examines the rationale behind implementing stopping rules and the controversies they generate.

Related Experiment Videos

Main Results:

  • Misunderstandings often stem from the complexity of statistical methods and ethical considerations.
  • Effective communication and clear guidelines are vital for proper implementation.
  • Successful application can expedite the availability of beneficial treatments and prevent exposure to harmful ones.

Conclusions:

  • Clarifying the purpose and application of stopping rules is necessary.
  • Promoting better understanding can enhance the ethical and efficient conduct of clinical trials.
  • Addressing controversies will foster greater trust and acceptance of trial outcomes.